Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    February 2017
  1. DE SMITH AJ, Kaur M, Gonseth S, Endicott AA, et al
    Correlates of prenatal and early-life tobacco smoke exposure and frequency of common gene deletions in childhood acute lymphoblastic leukemia.
    Cancer Res. 2017 Feb 15. pii: canres.2571.2016.
    PubMed     Text format     Abstract available


    January 2017
  2. TABE Y, Yamamoto S, Saitoh K, Sekihara K, et al
    Survival of acute monocytic leukemia cells is driven by fatty acid oxidation-mediated activation of AMPK in bone marrow adipocytes.
    Cancer Res. 2017 Jan 20. pii: canres.1645.2016.
    PubMed     Text format     Abstract available


  3. GAYMES TJ, Mohamedali A, Eiliazadeh A, Darling D, et al
    FLT3 and JAK2 mutations in acute myeloid leukemia promote inter-chromosomal homologous recombination and the potential for copy neutral loss of heterozygosity (CN-LOH).
    Cancer Res. 2017 Jan 20. pii: canres.1678.2016.
    PubMed     Text format     Abstract available


    December 2016
  4. SILVERBUSH D, Grosskurth S, Wang D, Powell F, et al
    Cell-specific computational modeling of the PIM pathway in acute myeloid leukemia.
    Cancer Res. 2016 Dec 13. pii: canres.1578.2016.
    PubMed     Text format     Abstract available


    November 2016
  5. ABDUL-AZIZ A, Shafat M, Mehta T, Di Palma F, et al
    MIF-induced stromal PKCbeta/IL8 is essential in human acute myeloid leukemia.
    Cancer Res. 2016 Nov 21. pii: canres.1095.2016.
    PubMed     Text format     Abstract available


  6. DING L, Sun QY, Tan KT, Chien W, et al
    Mutational landscape of pediatric acute lymphoblastic leukemia.
    Cancer Res. 2016 Nov 21. pii: canres.1303.2016.
    PubMed     Text format     Abstract available


  7. WEI TW, Wu PY, Wu TJ, Hou HA, et al
    Aurora A and NF-kappaB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA.
    Cancer Res. 2016 Nov 10. doi: 10.1158/0008-5472.CAN-16-1004.
    PubMed     Text format     Abstract available


    October 2016
  8. DUQUE-AFONSO J, Lin CH, Han K, Wei MC, et al
    E2A-PBX1 remodels oncogenic signaling networks in B-cell precursor acute lymphoid leukemia.
    Cancer Res. 2016 Oct 7. pii: canres.1899.2016.
    PubMed     Text format     Abstract available


  9. ZHENG X, Fan X, Fu B, Zheng M, et al
    EpCAM inhibition sensitizes chemoresistant leukemia to immune surveillance.
    Cancer Res. 2016 Oct 3. pii: canres.0842.2016.
    PubMed     Text format     Abstract available


    September 2016
  10. LI JM, Petersen CT, Li J, Panjwani R, et al
    Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Vasoactive Intestinal Peptide.
    Cancer Res. 2016 Sep 26. pii: canres.0427.2016.
    PubMed     Text format     Abstract available


  11. TRAER E, Martinez J, Javidi-Sharifi N, Agarwal A, et al
    FGF2 from marrow microenvironment promotes resistance to FLT3 inhibitors in acute myeloid leukemia.
    Cancer Res. 2016 Sep 26. pii: canres.3569.2016.
    PubMed     Text format     Abstract available



  12. Correction: An IkappaB alpha Inhibitor Causes Leukemia Cell Death through a p38 MAP Kinase-dependent, NF-kappaB-independent Mechanism.
    Cancer Res. 2016;76:5584.
    PubMed     Text format    


  13. SAMUEL J, Jayne S, Chen Y, Majid A, et al
    Posttranscriptional upregulation of p53 by reactive oxygen species in chronic lymphocytic leukemia.
    Cancer Res. 2016 Sep 7. pii: canres.0843.2016.
    PubMed     Text format     Abstract available


    August 2016
  14. GATJEN M, Brand F, Grau M, Gerlach K, et al
    Splenic marginal zone granulocytes acquire an accentuated neutrophil B cell-helper phenotype in chronic lymphocytic leukemia.
    Cancer Res. 2016 Aug 3. pii: canres.3486.2015.
    PubMed     Text format     Abstract available


    June 2016
  15. RICHMOND J, Robbins A, Evans K, Beck D, et al
    Acute sensitivity of Ph-like acute lymphoblastic leukemia to the SMAC-mimetic birinapant.
    Cancer Res. 2016 Jun 14. pii: canres.0523.2016.
    PubMed     Text format     Abstract available


  16. BACHEGOWDA L, Morrone K, Winski SL, Mantzaris I, et al
    Pexmetinib: a novel dual inhibitor of Tie-2 and p38 MAPK with efficacy in preclinical models of myelodysplastic syndromes and acute myeloid leukemia.
    Cancer Res. 2016 Jun 10. pii: canres.3062.2015.
    PubMed     Text format     Abstract available


  17. JIANG X, Bugno J, Hu C, Yang Y, et al
    Eradication of acute myeloid leukemia with FLT3 ligand-targeted miR-150 nanoparticles.
    Cancer Res. 2016 Jun 8. pii: canres.2949.2015.
    PubMed     Text format     Abstract available


    May 2016
  18. KOTHARI A, Hittelman WN, Chambers TC
    Cell cycle-dependent mechanisms underlie vincristine-induced death of primary acute lymphoblastic leukemia cells.
    Cancer Res. 2016 May 6. pii: canres.2104.2015.
    PubMed     Text format     Abstract available



  19. Correction: Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function.
    Cancer Res. 2016;76:2847.
    PubMed     Text format    


  20. SANDRI S, Bobisse S, Moxley K, Lamolinara A, et al
    Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.
    Cancer Res. 2016;76:2540-2551.
    PubMed     Text format     Abstract available


    March 2016
  21. YU ZY, Xiao H, Wang LM, Shen X, et al
    Natural product vibsanine A induces differentiation of myeloid leukemia cells through PKC activation.
    Cancer Res. 2016 Mar 16. pii: canres.1616.2015.
    PubMed     Text format     Abstract available


  22. FREIREICH E
    Commentary on Thomas and Epstein: "Bone Marrow Transplantation in Acute Leukemia".
    Cancer Res. 2016;76:1301-2.
    PubMed     Text format    


  23. CONERY AR, Centore RC, Spillane KL, Follmer NE, et al
    Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response.
    Cancer Res. 2016;76:1313-9.
    PubMed     Text format     Abstract available


  24. JOHNSON N, De Ieso P, Migliorini G, Orr N, et al
    Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  25. GUPTA K, Stefan T, Ignatz-Hoover J, Moreton S, et al
    GSK-3 inhibition sensitizes acute myeloid leukemia cells to 1,25D-mediated differentiation.
    Cancer Res. 2016 Mar 10. pii: canres.2290.2015.
    PubMed     Text format     Abstract available


  26. GRIESSINGER E, Anjos-Afonso F, Vargaftig J, Taussig D, et al
    Frequency and dynamics of leukemia-initiating cells during short-term ex vivo culture informs outcomes in acute myeloid leukemia patients.
    Cancer Res. 2016 Mar 9. pii: canres.2063.2015.
    PubMed     Text format     Abstract available


  27. DOLAI S, Sia KC, Robbins AK, Zhong L, et al
    Quantitative phosphotyrosine profiling of patient-derived xenografts identifies therapeutic targets in pediatric leukemia.
    Cancer Res. 2016 Mar 9. pii: canres.2786.2015.
    PubMed     Text format     Abstract available


  28. FARRAR JE, Schuback HL, Ries RE, Wai D, et al
    Genomic profiling of pediatric acute myeloid leukemia reveals a changing mutational landscape from disease diagnosis to relapse.
    Cancer Res. 2016 Mar 3. pii: canres.1015.2015.
    PubMed     Text format     Abstract available


  29. CLARKSON BD
    Commentary on Sandberg et al., "The In Vivo Chromosome Constitution of Marrow".
    Cancer Res. 2016;76:991-3.
    PubMed     Text format    


    February 2016
  30. GUO Y, Updegraff BL, Park S, Durakoglugil D, et al
    Comprehensive Ex Vivo Transposon Mutagenesis Identifies Genes That Promote Growth Factor Independence and Leukemogenesis.
    Cancer Res. 2016;76:773-86.
    PubMed     Text format     Abstract available


  31. KRENN PW, Hofbauer SW, Pucher S, Hutterer E, et al
    ILK induction in lymphoid organs by a TNFalpha-NF-kappaB-regulated pathway promotes the development of chronic lymphocytic leukemia.
    Cancer Res. 2016 Feb 2. pii: canres.3379.2015.
    PubMed     Text format     Abstract available


  32. MCGRATH JP, Williamson KE, Balasubramanian S, Odate S, et al
    Pharmacological inhibition of the histone lysine demethylase KDM1A suppresses the growth of multiple acute myeloid leukemia subtypes.
    Cancer Res. 2016 Feb 2. pii: canres.2333.2015.
    PubMed     Text format     Abstract available


  33. PRIETO C, Stam RW, Agraz-Doblas A, Ballerini P, et al
    Activated KRAS cooperates with MLLAF4 to promote extramedullary engraftment and migration of cord blood CD34+ HSPC but is insufficient to initiate leukemia.
    Cancer Res. 2016 Feb 2. pii: canres.2769.2015.
    PubMed     Text format     Abstract available


  34. CHEN WC, Yuan JS, Xing Y, Mitchell A, et al
    An integrated analysis of heterogeneous drug responses in acute myeloid leukemia that enables the discovery of predictive biomarkers.
    Cancer Res. 2016 Feb 1. pii: canres.2743.2015.
    PubMed     Text format     Abstract available


  35. LI Z, Chen P, Su R, Hu C, et al
    PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Cancer Res. 2016;76:619-29.
    PubMed     Text format     Abstract available


    January 2016
  36. ZHANG W, Borthakur G, Gao C, Chen Y, et al
    The dual MEK/FLT3 inhibitor E6201 exerts cytotoxic activity against acute myeloid leukemia cells harboring resistance-conferring FLT3 mutations.
    Cancer Res. 2016 Jan 28. pii: canres.1580.2015.
    PubMed     Text format     Abstract available


  37. WANG W, Zimmerman G, Huang X, Yu S, et al
    Aberrant Notch signaling in the bone marrow microenvironment of acute lymphoid leukemia suppresses osteoblast-mediated support of hematopoietic niche function.
    Cancer Res. 2016 Jan 22. pii: canres.2092.2015.
    PubMed     Text format     Abstract available


    December 2015
  38. MAXSON JE, Abel ML, Wang J, Deng X, et al
    Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.
    Cancer Res. 2015.
    PubMed     Text format     Abstract available



  39. Correction: CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy.
    Cancer Res. 2015;75:5167.
    PubMed     Text format    


  40. BAKER A, Gregory G, Verbrugge I, Kats L, et al
    The CDK9 inhibitor dinaciclib exerts potent apoptotic and antitumor effects in preclinical models of MLL-rearranged acute myeloid leukemia.
    Cancer Res. 2015 Dec 1. pii: canres.1070.2015.
    PubMed     Text format     Abstract available


    November 2015
  41. PICAUD S, Fedorov O, Thanasopoulou A, Leonards K, et al
    Generation of a selective small molecule inhibitor of the CBP/p300 bromodomain for leukemia therapy.
    Cancer Res. 2015 Nov 9. pii: canres.0236.2015.
    PubMed     Text format     Abstract available


  42. WALSH KM, de Smith AJ, Hansen HM, Smirnov IV, et al
    A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.
    Cancer Res. 2015.
    PubMed     Text format     Abstract available


    October 2015
  43. MITOBE Y, Yasunaga J, Furuta R, Matsuoka M, et al
    HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.
    Cancer Res. 2015;75:4143-52.
    PubMed     Text format     Abstract available


  44. CAPUANO C, Romanelli M, Pighi C, Cimino G, et al
    Anti-CD20 Therapy Acts via FcgammaRIIIA to Diminish Responsiveness of Human Natural Killer Cells.
    Cancer Res. 2015;75:4097-108.
    PubMed     Text format     Abstract available


    September 2015
  45. CLAPP GD, Lepoutre T, El Cheikh R, Bernard S, et al
    Implication of the autologous immune system in BCR-ABL transcript variations in chronic myelogenous leukemia patients treated with imatinib.
    Cancer Res. 2015 Sep 10. pii: canres.0611.2015.
    PubMed     Text format     Abstract available


    August 2015
  46. PATRUSSI L, Capitani N, Martini V, Pizzi M, et al
    Enhanced chemokine receptor recycling and impaired S1P1 expression promote leukemic cell infiltration of lymph nodes in chronic lymphocytic leukemia (CLL).
    Cancer Res. 2015 Aug 17. pii: canres.0986.2015.
    PubMed     Text format     Abstract available


    July 2015
  47. PORET N, Fu Q, Guihard S, Cheok M, et al
    CD38 in Hairy Cell Leukemia is a Marker of Poor Prognosis and a New Target for Therapy.
    Cancer Res. 2015 Jul 13. pii: canres.0893.2015.
    PubMed     Text format     Abstract available


    June 2015
  48. LEE EA, Angka L, Rota SG, Hanlon T, et al
    Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death.
    Cancer Res. 2015;75:2478-88.
    PubMed     Text format     Abstract available


  49. BRAUER-HARTMANN D, Hartmann JU, Wurm AA, Gerloff D, et al
    PML/RARalpha -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia.
    Cancer Res. 2015 Jun 3. pii: canres.3521.2014.
    PubMed     Text format     Abstract available


  50. MAXSON JE, Davare MA, Luty SB, Eide CA, et al
    Therapeutically Targetable ALK Mutations in Leukemia.
    Cancer Res. 2015;75:2146-50.
    PubMed     Text format     Abstract available


  51. VITALI C, Bassani C, Chiodoni C, Fellini E, et al
    SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias.
    Cancer Res. 2015;75:2387-99.
    PubMed     Text format     Abstract available


    May 2015
  52. YAMAZAKI J, Jelinek J, Lu Y, Cesaroni M, et al
    TET2 mutations affect non-CpG island DNA methylation at enhancers and transcription factor binding sites in chronic myelomonocytic leukemia.
    Cancer Res. 2015 May 13. pii: canres.0739.2014.
    PubMed     Text format     Abstract available


  53. SOUTHAM AD, Khanim FL, Hayden RE, Constantinou JK, et al
    Drug redeployment to kill leukaemia and lymphoma cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids.
    Cancer Res. 2015 May 5. pii: canres.0202.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: